2-Deoxy-D-ribose induces cellular damage by increasing oxidative stress and protein glycation in a pancreatic β-cell line

被引:26
作者
Koh, Gwanpyo [1 ,2 ]
Lee, Dae-Ho [1 ]
Woo, Jeong-taek [3 ]
机构
[1] Cheju Natl Univ, Sch Med, Dept Internal Med, Cheju 690756, South Korea
[2] Cheju Natl Univ, Inst Med Sci, Cheju 690756, South Korea
[3] Kyung Hee Univ, Sch Med, Dept Endocrinol & Metab, Seoul 130702, South Korea
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2010年 / 59卷 / 03期
关键词
DIABETIC COMPLICATIONS; MAILLARD REACTION; GLUCOSE TOXICITY; AUTOXIDATIVE GLYCOSYLATION; CHRONIC EXPOSURE; CROSS-LINKING; HIT CELLS; APOPTOSIS; OXYGEN; MECHANISM;
D O I
10.1016/j.metabol.2009.07.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2-Deoxy-o-ribose (dRib) is a sugar with a high reducing capacity. We previously reported that dRib induced damage in pancreatic beta-cells. The aim of this study was to investigate the mechanism of dRib-induced beta-cell damage. 2-Deoxy-o-ribose provoked cytotoxicity and apoptosis within 24 hours in HIT-T15 cells. Three antiglycating agents-diethylenctriaminepentaacetic acid, aminoguanidine, and pyridoxamine dose dependently inhibited dRib-triggered cytotoxicity and significantly suppressed apoptosis induced by dRib. 2-Deoxy-D-ribose increased intracellular reactive oxygen species and protein carbonyl levels in a dose-dependent manner. Diethylenetriaminepentaacetic acid and aminoguanidine significantly reduced dRib-induced rises in intracellular reactive oxygen species. All 3 inhibitors decreased the production of intracellular protein carbonyls by dRib. On incubation with albumin, dRib increased dicarbonyl and advanced glycation end product formation. Aminoguanidinc and pyridoxamine significantly decreased the dicarbonyl and advanced glycation end product augmentations. These results suggest that both oxidative stress and protein glycation are important mechanisms of dRib-induced damage in a pancreatic beta-cell line. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 43 条
[1]   Advanced glycation endproducts - role in pathology of diabetic complications [J].
Ahmed, N .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (01) :3-21
[2]   Role of oxidative stress in diabetic complications - A new perspective on an old paradigm [J].
Baynes, JW ;
Thorpe, SR .
DIABETES, 1999, 48 (01) :1-9
[3]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[4]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[5]  
BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669
[6]  
CARMICHAEL J, 1987, CANCER RES, V47, P936
[7]   Protein carbonylation in human diseases [J].
Dalle-Donne, I ;
Giustarini, D ;
Colombo, R ;
Rossi, R ;
Milzani, A .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (04) :169-176
[8]   GLYCATION, GLYCOXIDATION, AND CROSS-LINKING OF COLLAGEN BY GLUCOSE - KINETICS, MECHANISMS, AND INHIBITION OF LATE STAGES OF THE MAILLARD REACTION [J].
FU, MX ;
WELLSKNECHT, KJ ;
BLACKLEDGE, JA ;
LYONS, TJ ;
THORPE, SR ;
BAYNES, JW .
DIABETES, 1994, 43 (05) :676-683
[9]   Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis [J].
Giardino, I ;
Fard, AK ;
Hatchell, DL ;
Brownlee, M .
DIABETES, 1998, 47 (07) :1114-1120
[10]   MECHANISM OF PROTEIN MODIFICATION BY GLYOXAL AND GLYCOLALDEHYDE, REACTIVE INTERMEDIATES OF THE MAILLARD REACTION [J].
GLOMB, MA ;
MONNIER, VM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (17) :10017-10026